{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:08:27Z","timestamp":1771301307416,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s40263-012-0035-9","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T08:18:42Z","timestamp":1358929122000},"page":"185-195","source":"Crossref","is-referenced-by-count":13,"title":["A Revisited Strategy for Antiepileptic Drug Development in Children"],"prefix":"10.1007","volume":"27","author":[{"given":"Catherine","family":"Chiron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behrouz","family":"Kassai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Dulac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Pons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Nabbout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"issue":"8","key":"35_CR1","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1371\/journal.pmed.0050166","volume":"5","author":"S Rheims","year":"2008","unstructured":"Rheims S, Cucherat M, Arzimanoglou A, et al. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med. 2008;5(8):e166.","journal-title":"PLoS Med"},{"issue":"5742","key":"35_CR2","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1126\/science.309.5742.1799a","volume":"309","author":"X Bosch","year":"2005","unstructured":"Bosch X. Pediatric medicine: Europe follows U.S. in testing drugs for children [letter]. Science. 2005;309(5742):1799.","journal-title":"Science"},{"issue":"1","key":"35_CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003495-200868010-00002","volume":"68","author":"C Chiron","year":"2008","unstructured":"Chiron C, Dulac O, Pons G. Antiepileptic drug development in children: considerations for a revisited strategy. Drugs. 2008;68(1):17\u201325.","journal-title":"Drugs"},{"issue":"2","key":"35_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0920-1211(96)01006-6","volume":"26","author":"C Chiron","year":"1997","unstructured":"Chiron C, Dumas C, Jambaque I, et al. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 1997;26(2):389\u201395.","journal-title":"Epilepsy Res"},{"issue":"11","key":"35_CR5","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1528-1157.1999.tb02049.x","volume":"40","author":"RE Appleton","year":"1999","unstructured":"Appleton RE, Peters AC, Mumford JP, et al. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia. 1999;40(11):1627\u201333.","journal-title":"Epilepsia"},{"issue":"8","key":"35_CR6","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1212\/WNL.57.8.1416","volume":"57","author":"RD Elterman","year":"2001","unstructured":"Elterman RD, Shields WD, Mansfield KA, et al. Randomized trial of vigabatrin in patients with infantile spasms. Neurology. 2001;57(8):1416\u201321.","journal-title":"Neurology"},{"issue":"9242","key":"35_CR7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","volume":"356","author":"C Chiron","year":"2000","unstructured":"Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet. 2000;356(9242):1638\u201342.","journal-title":"Lancet"},{"key":"35_CR8","doi-asserted-by":"crossref","unstructured":"Chiron C, Dulac O, Beaumont D, et al. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 1991;Suppl. 2:S52\u2013S59.","DOI":"10.1177\/0883073891006002101"},{"issue":"11","key":"35_CR9","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1528-1157.1999.tb02048.x","volume":"40","author":"J Perez","year":"1999","unstructured":"Perez J, Chiron C, Musial C, et al. Stiripentol: efficacy and tolerability in children with epilepsy. Epilepsia. 1999;40(11):1618\u201326.","journal-title":"Epilepsia"},{"issue":"6","key":"35_CR10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-3476(95)70047-1","volume":"127","author":"FM Besag","year":"1995","unstructured":"Besag FM, Wallace SJ, Dulac O, et al. Lamotrigine for the treatment of epilepsy in childhood. J Pediatr. 1995;127(6):991\u20137.","journal-title":"J Pediatr"},{"issue":"8","key":"35_CR11","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1212\/WNL.53.8.1724","volume":"53","author":"M Duchowny","year":"1999","unstructured":"Duchowny M, Pellock JM, Graf WD, et al. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children: Lamictal Pediatric Partial Seizure Study Group. Neurology. 1999;53(8):1724\u201331.","journal-title":"Neurology"},{"key":"35_CR12","doi-asserted-by":"crossref","unstructured":"Dulac O, Chiron C, Luna D, et al. Vigabatrin in childhood epilepsy. J Child Neurol 1991;Suppl. 2:S30\u2013S37.","DOI":"10.1177\/0883073891006002071"},{"issue":"7","key":"35_CR13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","volume":"40","author":"LM Frank","year":"1999","unstructured":"Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia. 1999;40(7):973\u20139.","journal-title":"Epilepsia"},{"issue":"25","key":"35_CR14","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","volume":"337","author":"J Motte","year":"1997","unstructured":"Motte J, Trevathan E, Arvidsson JF, et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome: Lamictal Lennox-Gastaut Study Group. N Engl J Med. 1997;337(25):1807\u201312.","journal-title":"N Engl J Med"},{"issue":"2","key":"35_CR15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1528-1157.1994.tb02445.x","volume":"35","author":"E Schlumberger","year":"1994","unstructured":"Schlumberger E, Chavez F, Palacios L, et al. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia. 1994;35(2):359\u201367.","journal-title":"Epilepsia"},{"issue":"3","key":"35_CR16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0920-1211(96)00028-9","volume":"25","author":"C Chiron","year":"1996","unstructured":"Chiron C, Dulac O, Gram L. Vigabatrin withdrawal randomized study in children. Epilepsy Res. 1996;25(3):209\u201315.","journal-title":"Epilepsy Res"},{"issue":"5","key":"35_CR17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1528-1157.1998.tb01411.x","volume":"39","author":"AS Eriksson","year":"1998","unstructured":"Eriksson AS, Nergardh A, Hoppu K. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study. Epilepsia. 1998;39(5):495\u2013501.","journal-title":"Epilepsia"},{"issue":"3","key":"35_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0887-8994(97)00010-6","volume":"16","author":"K Farrell","year":"1997","unstructured":"Farrell K, Connolly MB, Munn R, et al. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy. Pediatr Neurol. 1997;16(3):201\u20135.","journal-title":"Pediatr Neurol"},{"issue":"11","key":"35_CR19","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","volume":"66","author":"TA Glauser","year":"2006","unstructured":"Glauser TA, Ayala R, Elterman RD, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology. 2006;66(11):1654\u201360.","journal-title":"Neurology"},{"issue":"21","key":"35_CR20","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","volume":"70","author":"T Glauser","year":"2008","unstructured":"Glauser T, Kluger G, Sachdeo R, et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology. 2008;70(21):1950\u20138.","journal-title":"Neurology"},{"issue":"5","key":"35_CR21","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1528-1167.2008.01981.x","volume":"50","author":"JE Pina-Garza","year":"2009","unstructured":"Pina-Garza JE, Nordli DR Jr, Rating D, et al. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia. 2009;50(5):1141\u20139.","journal-title":"Epilepsia"},{"key":"35_CR22","first-page":"439","volume":"41","author":"H Oguni","year":"1988","unstructured":"Oguni H, Hayashi K, Fukuyama Y. Phase III clinical study of the new antiepileptic drug AD-810, zonisamide, in childhood epilepsy. Jpn J Pediatr. 1988;41:439\u201350.","journal-title":"Jpn J Pediatr"},{"issue":"4","key":"35_CR23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.seizure.2010.12.017","volume":"20","author":"S Chhun","year":"2011","unstructured":"Chhun S, Troude P, Villeneuve N, et al. A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target. Seizure. 2011;20(4):320\u20135.","journal-title":"Seizure"},{"issue":"3","key":"35_CR24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0920-1211(03)00028-7","volume":"53","author":"Y Mikaeloff","year":"2003","unstructured":"Mikaeloff Y, Saint-Martin A, Mancini J, et al. Topiramate: efficacy and tolerability in children according to epilepsy syndromes. Epilepsy Res. 2003;53(3):225\u201332.","journal-title":"Epilepsy Res"},{"key":"35_CR25","doi-asserted-by":"crossref","unstructured":"Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30(4):389\u201399.","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"issue":"4","key":"35_CR26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","volume":"51","author":"AT Berg","year":"2010","unstructured":"Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009. Epilepsia. 2010;51(4):676\u201385.","journal-title":"Epilepsia"},{"issue":"8","key":"35_CR27","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1528-1157.1999.tb00833.x","volume":"40","author":"R Appleton","year":"1999","unstructured":"Appleton R, Fichtner K, LaMoreaux L, et al. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group. Epilepsia. 1999;40(8):1147\u201354.","journal-title":"Epilepsia"},{"issue":"7","key":"35_CR28","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1212\/WNL.52.7.1338","volume":"52","author":"RD Elterman","year":"1999","unstructured":"Elterman RD, Glauser TA, Wyllie E, et al. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children: Topiramate YP Study Group. Neurology. 1999;52(7):1338\u201344.","journal-title":"Neurology"},{"issue":"12","key":"35_CR29","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1212\/WNL.54.12.2237","volume":"54","author":"TA Glauser","year":"2000","unstructured":"Glauser TA, Nigro M, Sachdeo R, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures: the Oxcarbazepine Pediatric Study Group. Neurology. 2000;54(12):2237\u201344.","journal-title":"Neurology"},{"issue":"1","key":"35_CR30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archneur.55.1.56","volume":"55","author":"BM Uthman","year":"1998","unstructured":"Uthman BM, Rowan AJ, Ahmann PA, et al. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. Arch Neurol. 1998;55(1):56\u201362.","journal-title":"Arch Neurol"},{"issue":"9","key":"35_CR31","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1212\/01.wnl.0000186800.18456.72","volume":"65","author":"JE Pina-Garza","year":"2005","unstructured":"Pina-Garza JE, Espinoza R, Nordli DR, et al. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology. 2005;65(9):1370\u20135.","journal-title":"Neurology"},{"key":"35_CR32","doi-asserted-by":"crossref","unstructured":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome): the Felbamate Study Group in Lennox-Gastaut Syndrome. N Engl J Med 1993;328(1):29\u201333.","DOI":"10.1056\/NEJM199301073280105"},{"issue":"9","key":"35_CR33","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","volume":"52","author":"RC Sachdeo","year":"1999","unstructured":"Sachdeo RC, Glauser TA, Ritter F, et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome: Topiramate YL Study Group. Neurology. 1999;52(9):1882\u20137.","journal-title":"Neurology"},{"issue":"1","key":"35_CR34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0920-1211(95)00006-V","volume":"21","author":"A Richens","year":"1995","unstructured":"Richens A, Chadwick DW, Duncan JS, et al. Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial. Epilepsy Res. 1995;21(1):37\u201342.","journal-title":"Epilepsy Res"},{"issue":"Suppl. 1","key":"35_CR35","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1528-1157.1997.tb04517.x","volume":"38","author":"TA Glauser","year":"1997","unstructured":"Glauser TA. Preliminary observations on topiramate in pediatric epilepsies. Epilepsia. 1997;38(Suppl. 1):S37\u201341.","journal-title":"Epilepsia"},{"issue":"1","key":"35_CR36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1071-9091(97)80006-X","volume":"4","author":"Shinnar S Tiagabine","year":"1997","unstructured":"Tiagabine Shinnar S. Semin Pediatr Neurol. 1997;4(1):24\u201333.","journal-title":"Semin Pediatr Neurol"},{"issue":"3","key":"35_CR37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0920-1211(96)00070-8","volume":"25","author":"G Avanzini","year":"1996","unstructured":"Avanzini G, Canger R, Dalla BB, et al. Felbamate in therapy-resistant epilepsy: an Italian experience. Felbamate Italian Study Group. Epilepsy Res. 1996;25(3):249\u201355.","journal-title":"Epilepsy Res"},{"issue":"4","key":"35_CR38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.seizure.2005.02.004","volume":"14","author":"S Grosso","year":"2005","unstructured":"Grosso S, Franzoni E, Coppola G, et al. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure. 2005;14(4):248\u201353.","journal-title":"Seizure"},{"issue":"2\u20133","key":"35_CR39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0920-1211(00)00173-X","volume":"42","author":"P Uldall","year":"2000","unstructured":"Uldall P, Bulteau C, Pedersen SA, et al. Tiagabine adjunctive therapy in children with refractory epilepsy: a single-blind dose escalating study. Epilepsy Res. 2000;42(2\u20133):159\u201368.","journal-title":"Epilepsy Res"},{"issue":"Suppl. 1","key":"35_CR40","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.seizure.2004.04.018","volume":"13","author":"K Yagi","year":"2004","unstructured":"Yagi K. Overview of Japanese experience-controlled and uncontrolled trials. Seizure. 2004;13(Suppl. 1):S11\u20135.","journal-title":"Seizure"},{"issue":"1","key":"35_CR41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/TP.0b013e31817d5095","volume":"86","author":"JC Craig","year":"2008","unstructured":"Craig JC, Webster AC, Mitchell A, et al. Expanding the evidence base in transplantation: more and better randomized trials, and extending the value of observational data. Transplantation. 2008;86(1):32\u20135.","journal-title":"Transplantation"},{"issue":"8","key":"35_CR42","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1371\/journal.pmed.0050172","volume":"5","author":"TP Klassen","year":"2008","unstructured":"Klassen TP, Hartling L, Craig JC, et al. Children are not just small adults: the urgent need for high-quality trial evidence in children. PLoS Med. 2008;5(8):e172.","journal-title":"PLoS Med"},{"key":"35_CR43","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/08830738060210062101","volume":"21","author":"C Chiron","year":"2006","unstructured":"Chiron C, Tonnelier S, Rey E, et al. Stiripentol in childhood partial epilepsy: randomized placebo-controlled trial with enrichment and withdrawal design. J Child Neurol. 2006;21:496\u2013502.","journal-title":"J Child Neurol"},{"issue":"2","key":"35_CR44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1528-1167.2007.01423.x","volume":"49","author":"B Kassa\u00ef","year":"2008","unstructured":"Kassa\u00ef B, Chiron C, Augier S, et al. Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data. Epilepsia. 2008;49(2):343\u20138.","journal-title":"Epilepsia"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-012-0035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-012-0035-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-012-0035-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T15:45:09Z","timestamp":1562600709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-012-0035-9"}},"subtitle":["Designing an Initial Exploratory Step"],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1007\/s40263-012-0035-9","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}